{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:28:07Z","timestamp":1773354487678,"version":"3.50.1"},"reference-count":6,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>Dose delivery of hydrofluoroalkane-beclomethasone and chlorofluorocarbon-beclomethasone was compared during in vitro neonatal simulations: mechanical ventilation with 40% and 100% relative humidity + Neonatal Chamber-Ventilator System\/endotracheal tube; manual ventilation + Neonatal Chamber\/endotracheal tube; \u201cspontaneous breathing\u201d + Neonatal Chamber\/face mask without\/with manual assistance. The delivery of hydrofluoroalkane-beclomethasone was significantly greater in each simulation.<\/jats:p>","DOI":"10.1136\/adc.2002.022905","type":"journal-article","created":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T16:12:08Z","timestamp":1093018328000},"page":"F417-F418","source":"Crossref","is-referenced-by-count":6,"title":["Hydrofluoroalkane-beclomethasone versus chlorofluorocarbon-beclomethasone delivery in neonatal models: \n            Table 1"],"prefix":"10.1136","volume":"89","author":[{"given":"C H","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M P","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M W","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2004,8,20]]},"reference":[{"key":"2025090510012883000_89.5.F417.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904013401304"},{"key":"2025090510012883000_89.5.F417.2","doi-asserted-by":"publisher","DOI":"10.1136\/fn.80.3.F203"},{"key":"2025090510012883000_89.5.F417.3","first-page":"290","volume":"6","year":"1999","journal-title":"Can Respir J"},{"key":"2025090510012883000_89.5.F417.4","unstructured":"Leach C . Enhanced drug delivery through reformulating MDIs with HFA propellants: drug deposition and its effect on preclinical and clinical programs. In: Dalby RN, Byron PR, Farr SJ, eds. Respiratory drug delivery V. Buffalo Grove, IL: Interpharm Press, 1996:133\u00e2\u0080\u009344."},{"key":"2025090510012883000_89.5.F417.5","first-page":"1","volume":"10","year":"2000","journal-title":"Neonatal respiratory disease"},{"key":"2025090510012883000_89.5.F417.6","doi-asserted-by":"crossref","unstructured":"Finlay WH. The mechanics of inhaled pharmaceutical aerosols. London: Academic Press, 2001:47\u00e2\u0080\u009391.","DOI":"10.1016\/B978-012256971-5\/50005-5"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2002.022905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:02:14Z","timestamp":1757091734000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/adc.2002.022905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,20]]},"references-count":6,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,8,20]]},"published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1136\/adc.2002.022905"],"URL":"https:\/\/doi.org\/10.1136\/adc.2002.022905","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,20]]}}}